# CoVPN Vaccine Site Preparation

> **NIH NIH UM1** · FAMILY HEALTH INTERNATIONAL · 2020 · $169,587,659

## Abstract

Project Summary/Abstract
Given the rapid spread of SARS-CoV-2 infection, the on-going global pandemic, and the risk for seasonal
recurrence there is a critical need to test emerging vaccine candidates in phase 3 efficacy trials. Due to
its experience in implementation of global HIVAIDS prevention efficacy trials and its operational capacity
to respond to a new global pandemic, the HPTN, in collaboration with the HVTN, is providing operational
support for the newly constituted COVID-19 Prevention Network (CoVPN). Preparing for a series of
large scale efficacy trials, this application outlines aims required to build the infrastructure capacity to
rapidly implement them over the coming month. The requested funds are to prepare clinical trial sites
for implementation of these trials. The HPTN will support 30 clinical trials sites in the United States,
South America, and Sub-Saharan Africa so they can begin enrollment in NIH supported COVID-19 vaccine
and monoclonal trials planned for implementation over the next 6 months.

## Key facts

- **NIH application ID:** 10187741
- **Project number:** 3UM1AI068619-14S1
- **Recipient organization:** FAMILY HEALTH INTERNATIONAL
- **Principal Investigator:** MYRON Scott COHEN
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $169,587,659
- **Award type:** 3
- **Project period:** 2020-07-14 → 2020-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10187741

## Citation

> US National Institutes of Health, RePORTER application 10187741, CoVPN Vaccine Site Preparation (3UM1AI068619-14S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10187741. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*